Chimeric antigen receptor T cell therapy for multiple myeloma
Abstract Chimeric antigen receptor (CAR) T cell therapy is a new cancer immunotherapy targeting cancer-specific cell surface antigen. CD19-CAR T cells have been already shown to be very effective to B cell leukemia/lymphoma. Now, many researchers are developing CAR T cells for multiple myeloma. CAR...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2019-06-01
|
| Serier: | Inflammation and Regeneration |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s41232-019-0100-6 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|